Thymosin Alpha-1 vs Thymosin Beta-4: Immune vs Repair
Here is how these two compounds compare — based on published research, not marketing claims.
Thymosin Alpha-1
856
Indexed Studies
Human Trials
Evidence Level
Yes
Human Trials
Not Approved
FDA Status
Thymosin Beta-4
1038
Indexed Studies
Human Trials
Evidence Level
Yes
Human Trials
Not Approved
FDA Status
PSI OVERVIEW
Here is the key difference between these compounds and what it means for the research.
Both come from the thymus gland. Both have 'thymosin' in the name. But they do completely different things. Thymosin Alpha-1 is an immune modulator — it trains T-cells and enhances the adaptive immune response. Thymosin Beta-4 is a tissue repair protein — it regulates actin to help cells migrate to wound sites. The name similarity causes confusion. The biology is distinct.
Key Differences
| Attribute | Thymosin Alpha-1 | Thymosin Beta-4 |
|---|---|---|
| Evidence Level | Human Trials | Animal Studies |
| Category | Thymic Peptide | Thymic Peptide |
| Human Data | Extensive. Multiple clinical trials. Approved drug. Hundreds of publications. PSI rates L3. | Phase II trials for corneal healing. Less clinical depth than TA1. PSI rates L2. |
| Safety Profile | Approved in 30+ countries as Zadaxin. Decades of clinical safety data. Minimal side effects. | Clinical trial data for corneal healing. Generally well-tolerated. Limited long-term safety data. |
| Key Limitations | Not FDA-approved in the US. Some trials show modest effect sizes. | Clinical development has been slow. Some trials did not meet endpoints. |
Mechanism Comparison
HOW THEY WORK
These compounds work through different biological pathways. Here is how each one operates at the cellular level.
Thymosin Alpha-1
Activates dendritic cells, enhances T-cell maturation, and modulates cytokine production. Strengthens the adaptive immune system — the part that learns and remembers specific threats.
Thymosin Beta-4
Regulates actin polymerization — the protein skeleton inside cells that controls movement. When tissue is damaged, cells need to migrate to the injury. TB4 facilitates that migration. Also reduces inflammation and promotes blood vessel formation.
Thymosin Alpha-1 works on the immune system. Thymosin Beta-4 works on tissue structure. TA1 trains immune cells to fight better. TB4 helps cells move to where they need to be for repair. One is an immune instructor. The other is a cellular mobilizer. The only thing they share is their origin organ.
Research Evidence
RESEARCH EVIDENCE
Between these compounds, researchers have published over 1,894 indexed studies. Here are the key findings.
TA1 is L3 with regulatory approval in 30+ countries and extensive clinical data. TB4 is L2 with some clinical trials but less depth. TA1 has significantly more clinical validation.
For immune support, TA1 is the appropriate compound with clinical validation.
For tissue repair and wound healing, TB4 (or TB-500) is the relevant option.
Do not substitute one for the other — they serve completely different functions.
The name similarity is misleading — always verify which thymosin is being discussed.
Key Limitations
- •Not interchangeable despite similar names.
- •Different biological functions, different evidence levels.
- •TB4 clinical development has been slower than expected.
- •Neither is FDA-approved in the US.
PSI Verdict
SUPPORTED BY EVIDENCE
Thymosin Alpha-1 enhances adaptive immune function and has regulatory approval for hepatitis and immune support in 30+ countries. Thymosin Beta-4 promotes cell migration and wound healing through actin regulation in clinical trials.
NOT YET ESTABLISHED
They are not alternatives to each other. Using one expecting the other's effects is a misunderstanding of the biology.
CONFIDENCE LEVEL
High for the distinction. These are different peptides that share a name origin. TA1 has more clinical evidence. TB4 has a more specific tissue repair mechanism. Know which one you are discussing.
Community Discussion
WHAT THE COMMUNITY IS SAYING
PSI monitors discussions across peptide research and biohacking communities. These are reported experiences, not clinical evidence.
Thymosin Alpha-1
"Thymosin alpha-1 is the best peptide for immune support"Supported by published data
"People use it to prevent getting sick during travel"Plausible but unproven
"It helped during long COVID recovery"Anecdotal only
Thymosin Beta-4
"Thymosin Beta-4 is the same thing as TB-500"Partially accurate
"There's an eye drop version in clinical trials"Supported by evidence
Safety Comparison
SAFETY PROFILE
What is currently known about the safety of each compound based on available research.
Thymosin Alpha-1
Approved in 30+ countries as Zadaxin. Decades of clinical safety data. Minimal side effects.
Thymosin Beta-4
Clinical trial data for corneal healing. Generally well-tolerated. Limited long-term safety data.
TA1 has decades of safety data from regulated clinical use. TB4 has limited but clean safety data from clinical trials. Both are well-tolerated.
WHAT THE RESEARCH SUGGESTS
The names are similar. The functions are not. Thymosin Alpha-1 for immune modulation. Thymosin Beta-4 for tissue repair. Every discussion about 'thymosins' should specify which one.
Frequently Asked Questions
Explore Each Compound
For the full evidence profile, PSI Verdict, and indexed research data, visit each compound's dedicated page.
Looking for a physician experienced with peptide therapy?
Every physician in the PSI directory is individually verified for active licensure, board certification, and clinical peptide experience.
Browse the PSI Physician Directory →Explore Individual Research Pages
Related PSI Resources
Medical Disclaimer
This content is for educational and informational purposes only and does not constitute medical advice. The information presented reflects published research as indexed by PSI and should not be used to make treatment decisions. Always consult a qualified healthcare provider before starting, stopping, or modifying any treatment.